secwatch.observer — SEC 8-K summary
======================================

Issuer:     Processa Pharmaceuticals, Inc. (PCSA)
CIK:        0001533743
Form:       8-K
Filed at:   2026-02-19T23:59:59+00:00
Accession:  0001493152-26-007469
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 1.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Processa's binding term sheet with Intact Therapeutics for PCS12852 expires without deal
--------------------------------------------------------------------------------

- Binding Term Sheet dated June 17, 2025 with Intact Therapeutics expired February 12, 2026.
- No definitive license agreement was executed regarding PCS12852.
- Proposed amendment to the Yuhan Corporation License Agreement was not entered.
- Neither party has any remaining obligations under the expired term sheet.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1533743/000149315226007469/0001493152-26-007469-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1533743/000149315226007469/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-007469

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer